The Misinformation Machine: Big Pharmas Narrative Strategy In early 2025, the FDA announced that shortages of semaglutide and tirzepatide had been resolved
Everybody wants to work on peptides of different sorts, not just for GLP-1s, but even beyond that, noted Pingle, who operates from the companys Cambridge, Massachusettsbased facility
Nothing in this article constitutes medical advice or a therapeutic claim
Fat metabolism and the mitochondrial connection To understand why levocarnitine matters during tirzepatide therapy, you need to understand what happens inside the cell when the body enters a caloric deficit
We also see with PMDD, which is a extreme, extreme form of PMS, and even saying that is not doing its service in how bad it is, there's GABA alpha receptor dysfunction, and so allopregnanolone doesn't dock appropriately in the brain with endometriosis